Details for Patent: 10,603,384

✉ Email this page to a colleague

Which drugs does patent 10,603,384 protect, and when does it expire?

Patent 10,603,384 protects PREVYMIS and is included in one NDA.

This patent has fifty-two patent family members in thirty-six countries.

Summary for Patent: 10,603,384

Title:	Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative
Abstract:	The invention relates to pharmaceutical compositions, particularly for intravenous administration, containing {8-fluoro-2-[4-(3-methoxyphenyl)piperazine-1-yl]-3-[2-methoxy-5-(trifluor- omethyl)phenyl]-3,4-dihydroquinazoline-4-yl}acetic acid in combination with at least one of the cyclodextrin excipients, lysine and arginine; the method for its production; and its use in methods of treatment of and/or as a prophylactic for illnesses, particularly its use as an antiviral, preferably against cytomegaloviruses.
Inventor(s):	Paulus; Kerstin (Ratingen, DE), Schwab; Wilfried (Velbert, DE), Grunder; Dominique (Belp, CH), Van Hoogevest; Peter (Neustadt an der Weinstrasse, DE)
Assignee:	AICURIS GMBH & CO. KG (Wuppertal, DE)
Application Number:	14/381,290
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Compound; Delivery;

Drugs Protected by US Patent 10,603,384

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Merck Sharp Dohme	PREVYMIS	letermovir	SOLUTION;INTRAVENOUS	209940-001	Nov 8, 2017		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
Merck Sharp Dohme	PREVYMIS	letermovir	SOLUTION;INTRAVENOUS	209940-002	Nov 8, 2017		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 10,603,384

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	10 2012 101 680	Feb 29, 2012

PCT Information
PCT Filed	February 28, 2013	PCT Application Number:	PCT/EP2013/054114
PCT Publication Date:	September 06, 2013	PCT Publication Number:	WO2013/127970

International Family Members for US Patent 10,603,384

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2013224947	⤷ Sign Up
Brazil	112014020946	⤷ Sign Up
Canada	2865203	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.